269 related articles for article (PubMed ID: 32879391)
1. Novel miRNA signature for predicting the stage of hepatocellular carcinoma.
Yerukala Sathipati S; Ho SY
Sci Rep; 2020 Sep; 10(1):14452. PubMed ID: 32879391
[TBL] [Abstract][Full Text] [Related]
2. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
3. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
5. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
6. Identifying a miRNA signature for predicting the stage of breast cancer.
Yerukala Sathipati S; Ho SY
Sci Rep; 2018 Oct; 8(1):16138. PubMed ID: 30382159
[TBL] [Abstract][Full Text] [Related]
7. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients.
Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB
J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822
[TBL] [Abstract][Full Text] [Related]
8. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
Qin L; Huang J; Wang G; Huang J; Wu X; Li J; Yi W; Qin F; Huang D
J Cell Physiol; 2019 Dec; 234(12):23581-23595. PubMed ID: 31210353
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
11. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
12. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma.
Wei R; Huang GL; Zhang MY; Li BK; Zhang HZ; Shi M; Chen XQ; Huang L; Zhou QM; Jia WH; Zheng XF; Yuan YF; Wang HY
Clin Cancer Res; 2013 Sep; 19(17):4780-91. PubMed ID: 23812667
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
18. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
19. A novel microRNA signature predicts vascular invasion in hepatocellular carcinoma.
Han B; Zheng Y; Wang L; Wang H; Du J; Ye F; Sun T; Zhang L
J Cell Physiol; 2019 Nov; 234(11):20859-20868. PubMed ID: 30997686
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]